CMS Entry id: 2710 | Channel: News landing page | Template: news/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

News

13 May 2022

Investigating the Impact of COVID-19 on Cognition

Children of the 90s collaborates with researchers at Cambridge Cognition to investigate the cognitive impacts of COVID-19.


16 December 2021

Electronic Clinical Outcomes Assessment contract win worth over £500,000

Cambridge Cognition is pleased to announce that it has won a contract worth over £500,000 to provide electronic clinical outcome assessments ("eCOA"). 

9 December 2021

Cambridge Cognition wins £1.0m schizophrenia clinical trial contract

Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has secured a contract for an additional schizophrenia clinical trial worth £1.0m. 

26 October 2021

Cambridge Cognition wins contract for a pivotal schizophrenia trial

Cambridge Cognition, which develops and markets digital solutions to assess brain health, is pleased to announce that it has secured a contract for a further sizeable schizophrenia trial with an existing customer.

6 August 2021

Cambridge Cognition: COVID-19 Update

We would like to update you on the steps Cambridge Cognition is taking to ensure business continuity for all our customers as the widespread impact of COVID-19 (coronavirus) continues to affect so many globally.

1 July 2021

Spin-out of Monument Therapeutics

Cambridge Cognition is pleased to announce the completion of the spin-out of Monument Therapeutics, a drug development company applying digital phenotyping to central nervous system ("CNS") disorders.

28 June 2021

New £2.2 million contract for at-home cognitive testing in a virtual clinical trial

Cambridge Cognition has been selected as the cognitive assessment partner for a large at-home study.  The contract is valued at £2.2 million with revenue expected to be recognised by the Company over three years beginning in H2 2021.